MedsFacts.com




MedsFacts Meta-Analysis covering adverse side effect reports of NORTRIPTYLINE HYDROCHLORIDE patients who developed MYASTHENIA GRAVIS CRISIS.



Introduction: MedsFacts provides MD-approved analysis to help both patients and physicians accurately research and assess the risk-reward trade off for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration, social media, and MedsFacts user submissions. Between January 2004 and October 2012, 4 individuals taking NORTRIPTYLINE HYDROCHLORIDE reported MYASTHENIA GRAVIS CRISIS to the FDA. A total of 276 NORTRIPTYLINE HYDROCHLORIDE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

Topics covered: This page is designed to help you determine the relationship, if any, between NORTRIPTYLINE HYDROCHLORIDE and MYASTHENIA GRAVIS CRISIS. In doing so, we compare NORTRIPTYLINE HYDROCHLORIDE with other drugs that cause MYASTHENIA GRAVIS CRISIS, to help you evaluate whether or not NORTRIPTYLINE HYDROCHLORIDE causes MYASTHENIA GRAVIS CRISIS. Likewise, this page shows the most highly-reported side effects of NORTRIPTYLINE HYDROCHLORIDE, so you can see if MYASTHENIA GRAVIS CRISIS ranks among NORTRIPTYLINE HYDROCHLORIDE's most well-known side effects.


The Dashboard explained: The Dashboard first shows general Summary Statistics for NORTRIPTYLINE HYDROCHLORIDE and MYASTHENIA GRAVIS CRISIS, such as the raw number and percentage of patients in FDA reports who used NORTRIPTYLINE HYDROCHLORIDE and developed MYASTHENIA GRAVIS CRISIS.

We then display a pie-chart which shows, in aggregate, what we believe represents general physician opinion of the safety of NORTRIPTYLINE HYDROCHLORIDE. This pie-chart summarizes, for all FDA reports covering NORTRIPTYLINE HYDROCHLORIDE, whether or not the treating physician felt NORTRIPTYLINE HYDROCHLORIDE (versus other drugs the patient was taking) was responsible for the adverse side-effects. After the pie-chart, we itemize the most common side effects in FDA studies covering NORTRIPTYLINE HYDROCHLORIDE. You may click on any of these side effects to learn more about them, in general, or specifically for NORTRIPTYLINE HYDROCHLORIDE. Next, the Dashboard lists the most common reasons (indications) why NORTRIPTYLINE HYDROCHLORIDE was prescribed for patients. Finally, we identify the drugs most widely associated with MYASTHENIA GRAVIS CRISIS in FDA literature. You may also click on any of these statistic rows to view its own specific dashboard.

Dashboard view of our research literature concerning NORTRIPTYLINE HYDROCHLORIDE :

Summary Statistics
Reports of MYASTHENIA GRAVIS CRISIS in patients taking NORTRIPTYLINE HYDROCHLORIDE: 4
Reports of any side effect developing while on NORTRIPTYLINE HYDROCHLORIDE : 276
Percentage of NORTRIPTYLINE HYDROCHLORIDE patients where MYASTHENIA GRAVIS CRISIS is a reported side effect: 1.4492753623188%

FDA reports of any drug causing MYASTHENIA GRAVIS CRISIS : 71
Average percentage for all medicated patients where MYASTHENIA GRAVIS CRISIS is reported as a complication: 0.00044498608791734%
Physician opinion on NORTRIPTYLINE HYDROCHLORIDE as adverse event culprit:

(* global)
Most common side effects (or coexisting conditions) for patients taking NORTRIPTYLINE HYDROCHLORIDE:
PAIN & NORTRIPTYLINE HYDROCHLORIDE ( 35 patients)
COMPLETED SUICIDE & NORTRIPTYLINE HYDROCHLORIDE ( 28 patients)
ANXIETY & NORTRIPTYLINE HYDROCHLORIDE ( 28 patients)
FATIGUE & NORTRIPTYLINE HYDROCHLORIDE ( 27 patients)
DYSPNOEA & NORTRIPTYLINE HYDROCHLORIDE ( 25 patients)
BACK PAIN & NORTRIPTYLINE HYDROCHLORIDE ( 24 patients)
SOMNOLENCE & NORTRIPTYLINE HYDROCHLORIDE ( 22 patients)
OSTEOMYELITIS & NORTRIPTYLINE HYDROCHLORIDE ( 19 patients)
DEATH & NORTRIPTYLINE HYDROCHLORIDE ( 18 patients)
RIB FRACTURE & NORTRIPTYLINE HYDROCHLORIDE ( 18 patients)
WEIGHT DECREASED & NORTRIPTYLINE HYDROCHLORIDE ( 18 patients)
HYPOAESTHESIA & NORTRIPTYLINE HYDROCHLORIDE ( 17 patients)
OSTEOARTHRITIS & NORTRIPTYLINE HYDROCHLORIDE ( 17 patients)
PAIN IN JAW & NORTRIPTYLINE HYDROCHLORIDE ( 16 patients)
PAIN IN EXTREMITY & NORTRIPTYLINE HYDROCHLORIDE ( 16 patients)
PARAESTHESIA & NORTRIPTYLINE HYDROCHLORIDE ( 16 patients)
CHEST PAIN & NORTRIPTYLINE HYDROCHLORIDE ( 15 patients)
NAUSEA & NORTRIPTYLINE HYDROCHLORIDE ( 15 patients)
INJURY & NORTRIPTYLINE HYDROCHLORIDE ( 15 patients)
HYPERTENSION & NORTRIPTYLINE HYDROCHLORIDE ( 15 patients)
INTERVERTEBRAL DISC DEGENERATION & NORTRIPTYLINE HYDROCHLORIDE ( 14 patients)
DYSPHAGIA & NORTRIPTYLINE HYDROCHLORIDE ( 14 patients)
DEEP VEIN THROMBOSIS & NORTRIPTYLINE HYDROCHLORIDE ( 14 patients)
DIARRHOEA & NORTRIPTYLINE HYDROCHLORIDE ( 13 patients)
INSOMNIA & NORTRIPTYLINE HYDROCHLORIDE ( 13 patients)
TOXICITY TO VARIOUS AGENTS & NORTRIPTYLINE HYDROCHLORIDE ( 13 patients)
TOOTH EXTRACTION & NORTRIPTYLINE HYDROCHLORIDE ( 13 patients)
CARDIAC DISORDER & NORTRIPTYLINE HYDROCHLORIDE ( 13 patients)
MYALGIA & NORTRIPTYLINE HYDROCHLORIDE ( 13 patients)
DRUG INEFFECTIVE & NORTRIPTYLINE HYDROCHLORIDE ( 13 patients)
CONSTIPATION & NORTRIPTYLINE HYDROCHLORIDE ( 12 patients)
ARTHRALGIA & NORTRIPTYLINE HYDROCHLORIDE ( 12 patients)
ENDODONTIC PROCEDURE & NORTRIPTYLINE HYDROCHLORIDE ( 12 patients)
OSTEONECROSIS & NORTRIPTYLINE HYDROCHLORIDE ( 12 patients)
NEURALGIA & NORTRIPTYLINE HYDROCHLORIDE ( 11 patients)
GENERAL PHYSICAL HEALTH DETERIORATION & NORTRIPTYLINE HYDROCHLORIDE ( 11 patients)
NEUROPATHY PERIPHERAL & NORTRIPTYLINE HYDROCHLORIDE ( 11 patients)
PULMONARY EMBOLISM & NORTRIPTYLINE HYDROCHLORIDE ( 11 patients)
LOSS OF CONSCIOUSNESS & NORTRIPTYLINE HYDROCHLORIDE ( 11 patients)
GINGIVAL BLEEDING & NORTRIPTYLINE HYDROCHLORIDE ( 10 patients)
BURSITIS & NORTRIPTYLINE HYDROCHLORIDE ( 10 patients)
MUSCULOSKELETAL STIFFNESS & NORTRIPTYLINE HYDROCHLORIDE ( 10 patients)
HAIR GROWTH ABNORMAL & NORTRIPTYLINE HYDROCHLORIDE ( 10 patients)
FALL & NORTRIPTYLINE HYDROCHLORIDE ( 10 patients)
COMPRESSION FRACTURE & NORTRIPTYLINE HYDROCHLORIDE ( 10 patients)
PROSTATISM & NORTRIPTYLINE HYDROCHLORIDE ( 10 patients)
DIABETES MELLITUS & NORTRIPTYLINE HYDROCHLORIDE ( 10 patients)
DENTURE WEARER & NORTRIPTYLINE HYDROCHLORIDE ( 10 patients)
PERIODONTAL DISEASE & NORTRIPTYLINE HYDROCHLORIDE ( 10 patients)
User posts:
Most frequent diagnoses/indications for prescribing NORTRIPTYLINE HYDROCHLORIDE:
PRODUCT USED FOR UNKNOWN INDICATION ( 45 patients )
DRUG USE FOR UNKNOWN INDICATION ( 23 patients )
DEPRESSION ( 14 patients )
PAIN ( 7 patients )
MUSCLE SPASMS ( 3 patients )
PSYCHOTIC DISORDER ( 3 patients )
ANXIETY ( 3 patients )
INSOMNIA ( 3 patients )
MIGRAINE ( 3 patients )
NEUROPATHY PERIPHERAL ( 2 patients )
FIBROMYALGIA ( 2 patients )
NEURALGIA ( 2 patients )
ARTHRALGIA ( 2 patients )
MENTAL DISORDER ( 1 patients )
SMOKING CESSATION THERAPY ( 1 patients )
TEMPORAL ARTERITIS ( 1 patients )
COMPLEX REGIONAL PAIN SYNDROME ( 1 patients )
DRUG ABUSER ( 1 patients )
MAJOR DEPRESSION ( 1 patients )
PROPHYLAXIS OF NAUSEA AND VOMITING ( 1 patients )
SLEEP DISORDER THERAPY ( 1 patients )
SYNCOPE ( 1 patients )
ANTIDEPRESSANT THERAPY ( 1 patients )
DEMENTIA ( 1 patients )
DIZZINESS ( 1 patients )
HEADACHE ( 1 patients )
IRRITABLE BOWEL SYNDROME ( 1 patients )
( 0 patients )
Drugs with high rate of report for adverse event MYASTHENIA GRAVIS CRISIS:
THYROLAR-1 & MYASTHENIA GRAVIS CRISIS (33 patients)
MESTINON & MYASTHENIA GRAVIS CRISIS (15 patients)
PYRIDOSTIGMINE BROMIDE & MYASTHENIA GRAVIS CRISIS (8 patients)
FORTEO & MYASTHENIA GRAVIS CRISIS (8 patients)
ERYTHROMYCIN & MYASTHENIA GRAVIS CRISIS (7 patients)
TOPIRAMATE & MYASTHENIA GRAVIS CRISIS (7 patients)
OMEPRAZOLE & MYASTHENIA GRAVIS CRISIS (7 patients)
NEORAL & MYASTHENIA GRAVIS CRISIS (7 patients)
ACETAMINOPHEN & MYASTHENIA GRAVIS CRISIS (7 patients)
ASPIRIN & MYASTHENIA GRAVIS CRISIS (6 patients)
KETEK & MYASTHENIA GRAVIS CRISIS (6 patients)
SIMVASTATIN & MYASTHENIA GRAVIS CRISIS (5 patients)
ALBUTEROL & MYASTHENIA GRAVIS CRISIS (5 patients)
HYDROCHLOROTHIAZIDE & MYASTHENIA GRAVIS CRISIS (5 patients)
BIPERIDEN HYDROCHLORIDE TAB & MYASTHENIA GRAVIS CRISIS (4 patients)
HEPARIN & MYASTHENIA GRAVIS CRISIS (4 patients)
VICODIN & MYASTHENIA GRAVIS CRISIS (4 patients)
THYROID TAB & MYASTHENIA GRAVIS CRISIS (4 patients)
GLUCOPHAGE & MYASTHENIA GRAVIS CRISIS (4 patients)
TRAMADOL HCL & MYASTHENIA GRAVIS CRISIS (4 patients)
NORTRIPTYLINE HYDROCHLORIDE & MYASTHENIA GRAVIS CRISIS (4 patients)
AZATHIOPRINE & MYASTHENIA GRAVIS CRISIS (4 patients)
CLOZAPINE & MYASTHENIA GRAVIS CRISIS (4 patients)
RIZATRIPTAN & MYASTHENIA GRAVIS CRISIS (4 patients)
PREDNISONE TAB & MYASTHENIA GRAVIS CRISIS (4 patients)
IPILIMUMAB & MYASTHENIA GRAVIS CRISIS (4 patients)
PREDNISOLONE & MYASTHENIA GRAVIS CRISIS (4 patients)
PRAVASTATIN & MYASTHENIA GRAVIS CRISIS (4 patients)
GRANDAXIN (TOFISOPAM) & MYASTHENIA GRAVIS CRISIS (3 patients)
CISPLATIN & MYASTHENIA GRAVIS CRISIS (3 patients)
ETOPOSIDE & MYASTHENIA GRAVIS CRISIS (3 patients)
CYMBALTA & MYASTHENIA GRAVIS CRISIS (3 patients)
DOXORUBICIN HCL & MYASTHENIA GRAVIS CRISIS (3 patients)
FLEXERIL & MYASTHENIA GRAVIS CRISIS (3 patients)
COMBIVENT & MYASTHENIA GRAVIS CRISIS (3 patients)
LISINOPRIL & MYASTHENIA GRAVIS CRISIS (3 patients)
TORSEMIDE & MYASTHENIA GRAVIS CRISIS (3 patients)
TIKOSYN & MYASTHENIA GRAVIS CRISIS (3 patients)
SUBOXONE & MYASTHENIA GRAVIS CRISIS (3 patients)


Basic reports are available, free of charge, in PDF format and are suitable for scientific publication. Further data and analytics are available upon request. We are in the process of adding new features to our site, including Q&A interface for patients to speak with experts on medication. Check back with us again in the near future to see.





Copyright 2013 MedsFacts
info@medsfacts.com
Privacy Policy
Terms of use